DONATE

Search Results for:

IBEC celebrates its 20th anniversary with an institutional event at the Fundació Joan Miró

The Institute for Bioengineering of Catalonia (IBEC) celebrated its 20th anniversary on Wednesday 21 October with an institutional event at the Auditorium of the Fundació Joan Miró in Barcelona. Representatives of the Catalan Government, people who have led and supported the centre since its creation, and IBEC researchers looked back on two decades of research at the interface between engineering and the life sciences, and shared their views on the challenges ahead.

The “la Caixa” Foundation funds four health projects involving IBEC, two of them led by the institute

IBEC researchers Samuel Sánchez and Giuseppe Battaglia are leading two of the projects selected in the “la Caixa” Foundation’s 2026 health research and innovation calls. In addition, Pere Roca-Cusachs and Jordi Duran are members of the consortia behind two further projects. The four projects address challenges such as pseudomyxoma peritonei, bladder cancer, Lafora disease and frontotemporal dementia.

OPTOGEN 2026 brings more than 100 optogenetics and neurophotonics experts to Barcelona

From 12 to 14 October, the Barcelona Biomedical Research Park (PRBB) hosted the 11th International Workshop on Technologies for Optogenetics and Neurophotonics (OPTOGEN 2026), co-organised by the Institute for Bioengineering of Catalonia (IBEC) and the Institute of Photonic Sciences (ICFO). Over three days, more than a hundred scientists and technologists from around the world gathered to discuss the latest advances in optical methods and their applications in neuroscience, from new implantable devices to the latest molecular tools to study and control brain activity.

Ibec Seminar. Miguel Angel Pozo

Tension-sensing membrane domains in mechanoadaption and mechanotransduction MA del Pozo. Mechanoadaptation & Caveolae Biology Lab, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid 28029, Spain. madelpozo@cnic.es My lab aims to understand … Read more

Lab-designed molecule reduces amyloid beta, the protein linked to Alzheimer’s disease, in mice

A study led by the Institute for Bioengineering of Catalonia (IBEC) identifies a molecule, P33, that partially modulates the enzyme that initiates amyloid beta formation. The results, obtained in cell cultures and in mice, open up a new avenue of chemical research into the disease.

IBEC to take part in GLIOLIFE-AECC, the largest research consortium against glioblastoma

The group led by Irene Marco-Rius at IBEC is part of GLIOLIFE-AECC, a project funded with €10 million by the Spanish Association Against Cancer (AECC) and its Scientific Foundation to increase survival in people with glioblastoma, the most common and aggressive brain tumour in adults. The IBEC team will lead the consortium’s innovative radiology line, which will use an advanced imaging technique to study the tumour’s metabolism without the need for invasive procedures.